Alternatively, β-cell antigen, proinsulin, and HCTCAME can be effectively explored via their incorporation into EVs using post-isolation engineering methods that may produce multiple therapeutic effects in T1DM. The gene discussed is INS; the disease is type 1 diabetes mellitus.